alnylam
The Business Account Executive will focus on identifying and targeting healthcare providers treating patients with TTR amyloidosis to increase brand awareness and product adoption of AMVUTTRA™. The role involves developing territory strategies, building relationships with physicians and stakeholders, and achieving sales targets while collaborating closely with internal teams.
Headquarters
Cambridge, Massachusetts, United States
Company Size
1001-5000 employees
Founded
2002
Alnylam is a biopharmaceutical company that has pioneered RNA interference (RNAi) therapeutics, an innovative class of medicines that treats diseases by silencing the genes that cause or contribute to them. The company develops RNAi-based medicines targeting both rare and prevalent diseases across multiple therapeutic areas, with approved products and a robust investigational pipeline. Driven by science and inspired by patients, Alnylam is committed to delivering transformational medicines that address diseases at their genetic source.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for alnylam.
23% above the average for this role
Specialty Account Manager, Philadelphia – Eastern PA
Accord BioPharma
Account Executive - Neuromuscular
UCB
Account Executive Sr. / Las Vegas
UCB
Account Executive Sr. / Las Vegas
UCB
Account Specialist, Anti-Infectives - Nashville, TN
AbbVie
Territory Sales Executive - New Hampshire, Maine, Northeastern, Ma
CVS Health